Log in
Enquire now
‌

US Patent 8106221 Renin inhibitors

Patent 8106221 was granted and assigned to Vitae Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Vitae Pharmaceuticals
Vitae Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8106221
Patent Inventor Names
Zhenrong Xu0
Salvacion Cacatian0
Suresh B. Singh0
Wei Zhao0
Alexey V. Ishchenko0
Colin M. Tice0
David A. Claremon0
Gerard McGeehan0
...
Date of Patent
January 31, 2012
Patent Application Number
12665219
Date Filed
June 20, 2008
Patent Primary Examiner
‌
Kamal Saeed
Patent abstract

The present invention is directed to aspartic protease inhibitors. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8106221 Renin inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.